We thus analyzed the effect of AuPEI nanocomposites on tumor-infiltrating dendritic cells (TIDCs) based on the CD11c+CD45+ phenotype, which, according to the gating strategy, merely represents 4.44% of the whole cell population in untreated tumors. The gene discussed is ITGAX; the disease is neoplasm.